IKNA Ikena Revenue Growth QoQ

Symbol and logo of brand ikenaoncology.com (IKNA)

Quarterly revenue growth dynamics for Ikena Oncology, Inc. (IKNA) demonstrate the impact of a full outsourcing model for drug synthesis via US partners, with the current metric standing at 0.00. The company is currently strictly limiting R&D expenditures to focus on a single primary candidate while simultaneously developing a precision therapy system based on the analysis of specific tumor biomarkers.

IKNA (ikenaoncology.com) Quarterly Revenue Growth history from 07/04/2022 to 08/09/2025

Analytical breakdowns and data insights for company Ikena Oncology, Inc. (IKNA)

- stock price and consensus target price:
Fundamental valuation:Ikena (IKNA)
Mass-produced product of Ikena

This metric is calculated as the percentage change in sales volume between the current and previous quarters, allowing the investor to assess the business scaling rate and its solvency. For Ikena Oncology, Inc. (IKNA), which utilizes outsourcing for drug synthesis via CMOs, quarterly revenue dynamics serve as an indicator of this virtual model's efficiency, demonstrating the ability to generate cash flow without the costs of maintaining its own infrastructure.

Competitor analysis

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Quarterly Sales Growth Mural Oncology plc|Revenue Growth QoQ Kairos Pharma Inc|OKUR: Quarterly Revenue Increase|Quarterly Revenue Growth GDTC|CRIS (Curis) - Quarterly Revenue Increase|Revenue Growth QoQ apollomicsinc.com APLM|THAR: Sales Growth QoQ|advanbiomed.com - Quarterly Revenue Growth|Quarterly Revenue Increase GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Revenue Growth QoQ|Sunshine Biopharma Inc. (SBFM) - Quarterly Revenue Growth|XBIO (Xenetic Bio) - Quarterly Revenue Growth|Salarius Pharmaceuticals Inc (SLRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PPBT|Quarterly Revenue Growth American Oncology Network Inc (AONC)|Quarterly Revenue Growth BGNE (BeiGene Ltd.)|Sales Change QoQ CKPT (Checkpoint Therapeutics)|ELEV - Revenue Growth QoQ|ICAD (iCAD Inc.) - Sales Growth QoQ|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)